Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
13,882 total articles
SpaceX's blockbuster public debut and xAI momentum have revived speculative narratives about an eventual tie-up with Tesla. The facts on valuation, capital allocation, governance and regulatory optics argue against a straightforward merger. We propose a tactical short trade on TSLA to fade sentiment-driven strength: entry $405.04, stop $420.00, tar…
Fortinet's recent rally has pushed shares near the 52-week high, but fundamentals and structural AI/security tailwinds justify further upside. With revenue acceleration, strong free cash flow and unique silicon-enabled products, Fortinet is positioned to capture outsized security spending from AI data center buildouts. This trade plan sets an entry…
Nvidia remains the primary beneficiary of the AI buildout. The stock trades at a premium - $208.65 today - but fundamentals (high ROE, massive free cash flow, and dominant data center positioning) support a patient long. This trade plan targets $260 with a $188 stop over a 180-trading-day horizon, balancing upside from continued data-center demand …
Allot has tangible CSaaS traction (record ARR of $25.2M) and recent telco wins that make its recurring-revenue mix the key catalyst. With a market cap of roughly $335.6M and EV/sales near 2.4x, the stock offers asymmetric upside if ARR growth sustains and free cash flow recovers. Trade plan: enter $6.85, target $9.50, stop $6.00; primary horizon: m…
DigitalOcean has retooled into an AI-native cloud for SMBs and mid-market customers. With AI ARR up >200% and management guiding to accelerate revenue growth while tripling capacity by early 2028, we upgrade DOCN to a long. We expect free cash flow to roughly double over the next 12-24 months as utilization improves and gross margins expand, suppor…
Nano Nuclear Energy (NNE) is a pre-revenue microreactor developer that has accumulated strategic assets, submitted regulatory filings and inked partnerships that make it a plausible acquisition target for larger infrastructure or AI-infrastructure players. At roughly $1.38 billion market cap and heavy short interest, the stock offers an asymmetric …
Nvidia is trading near $209 with a $5.14 trillion market cap, strong profitability (ROE ~82%), and cash generation (free cash flow $119.1B). Valuation is rich on surface metrics (P/E ~32, P/FCF ~43) but still arguably discounts only a fraction of expected AI-driven revenue expansion. This trade idea sets an entry at $208.99, a stop at $184.00 and a…
Upbound Group (UPBD) trades like a beaten-down cyclical with a fat dividend and better-than-expected cash generation. At roughly $18.45 and a market cap near $1.08B, the stock screens cheap on P/E (~12.7) and EV/EBITDA (~1.2) while producing meaningful free cash flow. This is a trade idea for disciplined investors: enter near $18.45, protect with a…
Rivian is a play on execution: a lower-priced R2 hitting deliveries, targeted cost cuts, and improving unit economics create a near-term path to outsized upside. At $15.40 and a $19.4B market cap, the risk/reward looks attractive for a mid-term swing trade while production and demand risks remain real.
Capital One is trading like a confident, self-insured growth story even though its return profile is weak and credit exposure is concentrated in cards and consumer lending. The market is baking in successful Discover integration and benign credit cycles. If a recession or uptick in charge-offs materializes, the stock has asymmetric downside versus …
TJX Companies still delivers steady comp growth, strong free cash flow and an inflation-resilient model, but it trades at a premium versus historical norms. The trade: initiate a cautious long on a pullback to $160 with a $152 stop and a $180 target over a mid-term (45 trading days) horizon. Risk-reward is attractive if the stock gives a discipline…
Citizens Financial Services (CZFS) has posted consecutive quarters of improved net income driven by higher net interest income and lower credit loss provisions. With a market cap near $323M, a P/E around 8.3 and P/B under 1.0, the stock offers a value entry while technicals suggest constructive momentum. This trade idea outlines a mid-term long set…
Comstock appears to be pivoting from legacy, low-return assets toward higher-potential exploration targets by monetizing non-core holdings. That strategy could deliver funding, limit dilution, and catalyze a re-rating if drill results validate the thesis. This is a high-risk, asymmetric trade: entry at $1.20, target $2.00, stop $0.80, horizon 180 t…
Sumitomo Mitsui Financial Group (SMFG) is trading near its 52-week high but still looks attractive: market cap ~$159.8B, P/E ~15.4, P/B ~1.62 and a 2.16% yield. With higher domestic rates feeding net interest income and technicals showing momentum, I recommend a long trade sized for conviction with a $25.00 entry, $28.00 target and $23.00 stop over…
Immersion (IMMR) trades at a sub-$250M market cap with attractive valuation multiples (P/B ~0.75, EV/Sales ~0.12) and a 3.6% yield. The business is licensing-heavy with recurring royalties and a deep patent portfolio in haptics. For investors willing to tolerate uneven cash flow, a disciplined long position around $6.48 targets the $8.15 52-week hi…
Amazon shares are trading below $240 after a sharp pullback. With AWS capturing outsized AI infrastructure demand, modest multiple expansion on current earnings could lift the stock into the $290s. This trade idea lays out an actionable long with entry, stop and target, plus catalysts and risks to monitor.
Braze just reported another beat-and-raise quarter with revenue growth accelerating to ~30% and management launching a meaningful buyback. At a $2.1B market cap, the stock looks like a high-conviction swing trade: entry near $18.50, protective stop at $16.50 and a 45-trading-day target of $26.00. The case rests on continued top-line momentum, bette…
REalloys (ALOY) has moved from story stock to execution stage: a $20.6m investment in Saskatchewan processing, a 15-year offtake for Tanbreez heavy rare earths, and fresh capital position the company to capture premium pricing ahead of the Pentagon's 01/01/2027 ban on Chinese-origin rare earths. The technical set is frothy, but fundamentals and str…
Merck's oncology franchise remains the engine pushing the company higher. With Keytruda still dominant across multiple indications, an expanding slate of oncology programs, a $14.1B free cash flow runway and a $281B market cap, MRK looks attractive for a defined, 180-trading-day long trade. Entry at $114.00, stop at $106.00, target $130.00.
Forgent Power Solutions (FPS) is positioned to benefit from a multi-year data-center power refresh. Momentum indicators are constructive, volume is rising, and short interest remains manageable. We lay out an actionable mid-term swing trade with entry at $62.15, a $75 target and a $56 stop, and explain the fundamental and technical evidence behind …
Alamos Gold looks attractively discounted relative to its quality: steady production profile, low jurisdictional risk, and sensible capital allocation. We upgrade to a long trade with a clear entry, stop and target across a mid-term horizon, framing catalysts and risks that could drive a re-rating.
Lam Research sits at the intersection of an AI-driven memory supercycle, accelerated packaging complexity, and renewed chip-equipment capex. The company’s profitability, cash generation and low leverage justify buying on strength with a disciplined stop. I recommend a long trade with an entry at $397.24, a stop loss at $345.00 and a target at $520.…
The software dip through spring felt indiscriminate. XSW - an equal-weighted software & services ETF trading at $162.54 - now offers three concrete trade plans for different horizons that balance upside back toward the 52-week range with disciplined stops near the recent low. The setup is supported by valuation gaps, moderate short interest, and te…
Remitly turned profitable in 2025 after a period of heavy reinvestment and now trades at a reasonable multiple vs. its growth runway. With $1.64B revenue, 9.3M customers, and $243M in free cash flow, the company looks set to compound while expanding margins through scale, AI fraud reduction, and platform integrations. This trade idea lays out an ac…
Summit Therapeutics (SMMT) is a binary, catalyst-driven biotech trade centered on the FDA's PDUFA date for ivonescimab on 11/14/2026. The company trades at a $10.8B market cap, heavy short interest, and material intraday volume swings. This idea is a high-risk long with a defined entry, stop and target—intended for traders looking to play the appro…
